NO20020573L - Sekvens - Google Patents

Sekvens

Info

Publication number
NO20020573L
NO20020573L NO20020573A NO20020573A NO20020573L NO 20020573 L NO20020573 L NO 20020573L NO 20020573 A NO20020573 A NO 20020573A NO 20020573 A NO20020573 A NO 20020573A NO 20020573 L NO20020573 L NO 20020573L
Authority
NO
Norway
Prior art keywords
isav
acid sequences
sequences
sequence
salmonids
Prior art date
Application number
NO20020573A
Other languages
English (en)
Other versions
NO20020573D0 (no
NO328740B1 (no
Inventor
Steven Griffiths
Rachel Jane Ritchie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020573(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918588.6A external-priority patent/GB9918588D0/en
Priority claimed from GB0005848A external-priority patent/GB0005848D0/en
Priority claimed from GB0006674A external-priority patent/GB0006674D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20020573D0 publication Critical patent/NO20020573D0/no
Publication of NO20020573L publication Critical patent/NO20020573L/no
Publication of NO328740B1 publication Critical patent/NO328740B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Color Image Communication Systems (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20020573A 1999-08-07 2002-02-05 Sammensetninger og vaksine, samt anvendelse av sammensetningene for fremstilling av en vaksine for beskyttelse av fisk mot infeksiøs lakseanemivirus NO328740B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918588.6A GB9918588D0 (en) 1999-08-07 1999-08-07 Sequence
GB0005848A GB0005848D0 (en) 2000-03-11 2000-03-11 Sequence
GB0006674A GB0006674D0 (en) 2000-03-21 2000-03-21 Sequence
PCT/GB2000/002976 WO2001010469A2 (en) 1999-08-07 2000-08-07 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines

Publications (3)

Publication Number Publication Date
NO20020573D0 NO20020573D0 (no) 2002-02-05
NO20020573L true NO20020573L (no) 2002-04-05
NO328740B1 NO328740B1 (no) 2010-05-03

Family

ID=27255591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020573A NO328740B1 (no) 1999-08-07 2002-02-05 Sammensetninger og vaksine, samt anvendelse av sammensetningene for fremstilling av en vaksine for beskyttelse av fisk mot infeksiøs lakseanemivirus

Country Status (12)

Country Link
US (7) US6919083B1 (no)
EP (2) EP1637614A3 (no)
AT (1) ATE332712T1 (no)
AU (1) AU6304100A (no)
CA (1) CA2378437C (no)
CY (1) CY1106175T1 (no)
DE (1) DE60029327T2 (no)
DK (2) DK1200132T4 (no)
ES (1) ES2267553T3 (no)
NO (1) NO328740B1 (no)
PT (1) PT1200132E (no)
WO (1) WO2001010469A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637614A3 (en) 1999-08-07 2006-11-29 Novartis AG Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus)
DK1094069T4 (da) * 1999-10-18 2008-07-21 Intervet Int Bv DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
WO2001066569A1 (en) * 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
AU2001295584A1 (en) * 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus
GB0216414D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
US20130243803A1 (en) * 2012-03-09 2013-09-19 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus
EP4077355A1 (en) * 2019-12-20 2022-10-26 Intervet International B.V. Reassorted isa virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (no) 1999-05-31 2001-12-27 Genomar Asa DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
EP1637614A3 (en) 1999-08-07 2006-11-29 Novartis AG Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus)
DK1094069T4 (da) 1999-10-18 2008-07-21 Intervet Int Bv DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
WO2001049712A2 (en) 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
WO2001066569A1 (en) 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
AU2001295584A1 (en) 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus

Also Published As

Publication number Publication date
DK1200132T3 (da) 2006-10-23
CA2378437C (en) 2014-01-21
DK177298B1 (en) 2012-10-15
US7998484B2 (en) 2011-08-16
EP1637614A2 (en) 2006-03-22
US7128917B2 (en) 2006-10-31
US20070041988A1 (en) 2007-02-22
CY1106175T1 (el) 2011-06-08
US20050164176A1 (en) 2005-07-28
ATE332712T1 (de) 2006-08-15
EP1200132B2 (en) 2010-02-17
US20050261227A1 (en) 2005-11-24
ES2267553T3 (es) 2007-03-16
EP1200132B1 (en) 2006-07-12
US20120071630A1 (en) 2012-03-22
PT1200132E (pt) 2006-11-30
NO20020573D0 (no) 2002-02-05
DK200200167A (da) 2002-04-02
US20100136038A1 (en) 2010-06-03
WO2001010469A3 (en) 2001-09-07
CA2378437A1 (en) 2001-02-15
DE60029327D1 (de) 2006-08-24
EP1200132A2 (en) 2002-05-02
WO2001010469A2 (en) 2001-02-15
NO328740B1 (no) 2010-05-03
AU6304100A (en) 2001-03-05
US7199108B2 (en) 2007-04-03
DK1200132T4 (da) 2010-04-19
US20040146860A1 (en) 2004-07-29
EP1637614A3 (en) 2006-11-29
US6919083B1 (en) 2005-07-19
DE60029327T2 (de) 2007-07-05
US7201910B2 (en) 2007-04-10

Similar Documents

Publication Publication Date Title
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
IL233223A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
ATE367398T1 (de) Verfahren zur rückfaltung von proteinen mit freien cysteinresten
ATE118352T1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
ES2095852T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
DE60010285D1 (de) Verfahren zur Herstellung von Amino-Oxide
NO20020573L (no) Sekvens
ATE495247T1 (de) Chromoprotein und fluoroproteine
ATE447612T1 (de) Fluoreszenzproteine
DE69939114D1 (de) Nukleinsäuresequenzfamilie und entsprechende proteinsequenzen, die humane endogene retrovirale motive enthalten, und ihre anwendungen
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
NO20005608L (no) Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
DK1094069T4 (da) DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
ATE484582T1 (de) Aus koji-schimmelpilz stammende phospholipase a2
DE60119458D1 (de) Vorrichtung zur Feststellung der genetischen Sequenz von Biopolymeren
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2003104478A3 (en) Detection of rna structural elements
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
TH40453A (th) ยีน dtsR ที่ไวต่ออุณหภูมิ
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: NOVARTIS TIERGESUNDHEIT AG, CH

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ELANCO TIERGESUNDHEIT AG, CH

MK1K Patent expired